Aarti Drugs Ltd banner

Aarti Drugs Ltd
NSE:AARTIDRUGS

Watchlist Manager
Aarti Drugs Ltd Logo
Aarti Drugs Ltd
NSE:AARTIDRUGS
Watchlist
Price: 376.85 INR 0.59% Market Closed
Market Cap: ₹34.4B

Wall Street
Price Targets

AARTIDRUGS Price Targets Summary
Aarti Drugs Ltd

Wall Street analysts forecast AARTIDRUGS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AARTIDRUGS is 608.94 INR with a low forecast of 602.97 INR and a high forecast of 626.85 INR.

Lowest
Price Target
602.97 INR
60% Upside
Average
Price Target
608.94 INR
62% Upside
Highest
Price Target
626.85 INR
66% Upside
Aarti Drugs Ltd Competitors:
Price Targets
ISN
Intershop Holding AG
3% Upside
KRUS
Kura Sushi USA Inc
-3% Downside

Revenue
Forecast

10% / Year
Past Growth
14% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
10% / Year
Past Growth
14% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

For the last 13 years the compound annual growth rate for Aarti Drugs Ltd's revenue is 10%. The projected CAGR for the next 3 years is 14%.

Operating Income
Forecast

12% / Year
Past Growth
24% / Year
Estimated Growth
Estimates Accuracy
-11%
Average Miss
12% / Year
Past Growth
24% / Year
Estimated Growth
Estimates Accuracy
-11%
Average Miss

For the last 13 years the compound annual growth rate for Aarti Drugs Ltd's operating income is 12%. The projected CAGR for the next 3 years is 24%.

Net Income
Forecast

17% / Year
Past Growth
24% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat
17% / Year
Past Growth
24% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat

For the last 13 years the compound annual growth rate for Aarti Drugs Ltd's net income is 17%. The projected CAGR for the next 3 years is 24%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is AARTIDRUGS's stock price target?
Price Target
608.94 INR

According to Wall Street analysts, the average 1-year price target for AARTIDRUGS is 608.94 INR with a low forecast of 602.97 INR and a high forecast of 626.85 INR.

What is Aarti Drugs Ltd's Revenue forecast?
Projected CAGR
14%

For the last 13 years the compound annual growth rate for Aarti Drugs Ltd's revenue is 10%. The projected CAGR for the next 3 years is 14%.

What is Aarti Drugs Ltd's Operating Income forecast?
Projected CAGR
24%

For the last 13 years the compound annual growth rate for Aarti Drugs Ltd's operating income is 12%. The projected CAGR for the next 3 years is 24%.

What is Aarti Drugs Ltd's Net Income forecast?
Projected CAGR
24%

For the last 13 years the compound annual growth rate for Aarti Drugs Ltd's net income is 17%. The projected CAGR for the next 3 years is 24%.

Back to Top